These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 20621456)
21. Pragmatic measures in paediatric psychopharmacology--are we getting it right? Coghill D Eur Neuropsychopharmacol; 2011 Aug; 21(8):571-83. PubMed ID: 21194897 [TBL] [Abstract][Full Text] [Related]
22. Psychopharmacology for children: from off label use to registration. Wohlfarth T; Kalverdijk L; Rademaker C; Schothorst P; Minderaa R; Gispen-de Wied C Eur Neuropsychopharmacol; 2009 Aug; 19(8):603-8. PubMed ID: 19428221 [TBL] [Abstract][Full Text] [Related]
23. Will children with cancer benefit from the new European Paediatric Medicines Regulation? Vassal G Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857 [TBL] [Abstract][Full Text] [Related]
24. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products. Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425 [TBL] [Abstract][Full Text] [Related]
25. Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. Deveaugh-Geiss J; March J; Shapiro M; Andreason PJ; Emslie G; Ford LM; Greenhill L; Murphy D; Prentice E; Roberts R; Silva S; Swanson JM; VAN Zwieten-Boot B; Vitiello B; Wagner KD; Mangum B J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):261-270. PubMed ID: 16540810 [TBL] [Abstract][Full Text] [Related]
26. Impact of the new european paediatric regulatory framework on ethics committees: overview and perspectives. Altavilla A; Manfredi C; Baiardi P; Dehlinger-Kremer M; Galletti P; Pozuelo AA; Chaplin J; Ceci A Acta Paediatr; 2012 Jan; 101(1):e27-32. PubMed ID: 21732978 [TBL] [Abstract][Full Text] [Related]
27. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472 [TBL] [Abstract][Full Text] [Related]
28. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration. Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466 [TBL] [Abstract][Full Text] [Related]
29. The placebo problem in child and adolescent psychiatry. Simeon JG; Wiggins DM Acta Paedopsychiatr; 1993; 56(2):119-22. PubMed ID: 8135109 [TBL] [Abstract][Full Text] [Related]
30. Demography of paediatric renal care in Europe: organization and delivery. Ehrich JH; El Gendi AA; Drukker A; Janda J; Stefanidis C; Verrier-Jones K; Collier J; Katz M Nephrol Dial Transplant; 2005 Feb; 20(2):297-305. PubMed ID: 15173377 [TBL] [Abstract][Full Text] [Related]
31. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation. Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869 [TBL] [Abstract][Full Text] [Related]
32. Pain and symptom control in paediatric palliative care. Stevens MM; Dalla Pozza L; Cavalletto B; Cooper MG; Kilham HA Cancer Surv; 1994; 21():211-31. PubMed ID: 8564995 [TBL] [Abstract][Full Text] [Related]
33. JACIE accreditation in paediatric haemopoietic SCT. Cornish JM Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S82-6. PubMed ID: 18978752 [TBL] [Abstract][Full Text] [Related]
34. Teaching evidence-based medicine pediatric psychopharmacology: integrating psychopharmacologic treatment into the broad spectrum of care. Chrisman AK; Enderlin HT; Landry KL; Colvin JS; DeJohn MR Child Adolesc Psychiatr Clin N Am; 2007 Jan; 16(1):165-81, x. PubMed ID: 17141123 [TBL] [Abstract][Full Text] [Related]
35. Psychopharmacology of depression in children and adolescents. Smiga SM; Elliott GR Pediatr Clin North Am; 2011 Feb; 58(1):155-71, xi. PubMed ID: 21281854 [TBL] [Abstract][Full Text] [Related]
36. Neonatal drug trials: impact of EU and US paediatric regulations. Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777 [No Abstract] [Full Text] [Related]
37. Inappropriate oral formulations and information in paediatric trials. Pandit S; Shah U; Kirby DJ; Nunn T; Tuleu C Arch Dis Child; 2010 Sep; 95(9):754-6. PubMed ID: 20605870 [TBL] [Abstract][Full Text] [Related]
38. Forensic child and adolescent psychiatry: a review of the past 10 years. Ash P; Derdeyn AP J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1493-502. PubMed ID: 9394933 [TBL] [Abstract][Full Text] [Related]
39. The European Regulation on medicines for paediatric use. Dunne J Paediatr Respir Rev; 2007 Jun; 8(2):177-83. PubMed ID: 17574163 [TBL] [Abstract][Full Text] [Related]
40. Drug development for children: how is pharma tackling an unmet need? Hawcutt DB; Smyth RL IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]